Back To Search Instructions
Protocols
16 protocols meet the specified criteria
Disease Site: Lymphoid Leukemia
Protocol No.TitleStatus
0500000106Classification of Acute Lymphoblastic LeukemiaOpen
0500000142High Risk B-Precursor Acute Lymphoblastic LeukemiaOpen
0500000226Arizona Lymphoid Tissue and Blood Repository (ALTBR)Open
0800000386Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL)Open
0800001071A Phase II, Open-Label Study of Bortezomib (Velcade), Cladribine and Rituximab (VCR) in Advanced, Newly Diagnosed and Relapsed/Refractory Mantle Cell and Indolent Lymphomas (ProtocolOpen
0900000679A Phase II Study Of Reduced-Intensity Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT) For Treatment Of Hematologic Malignancies And Hematopoietic Failure StatesOpen
0900000822COG AALL0433: Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine StrategiesOpen
0900000967Lymphoma Outcomes and Epidemiological DatabaseOpen
1000000383Intensified Tyrosine Kinase Inhibitor Therapy (Dasatinib: IND # 73969, NSC # 732517) in Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (ALL)Open
1000000637COG AALL08B1: Classification of Newly Diagnosed Acute Lymphoblastic Leukemia (ALL)Open
1000000638COG AALL0932: Treatment of Patients with Newly Diagnosed Standard Risk B-precursor Acute Lymphoblastic Leukemia (ALL)Open
1100000353A Phase 1 Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma (M12-175) Open
1100000429Phase 1b, Escalating Dose Study of AVL-292, a Bruton's Tyrosine Kinase (Btk) Inhibitor, as Monotherapy in Subjects with Relapsed and/or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's MacroglobulinemiaOpen
1300000394A Phase 2 Open-Label Study of the Efficacy of ABT-199 (GDC-0199) in Subjects with Relapsed or Refractory Chronic Lymphocytic Leukemia Harboring the 17p Deletion (M13-982)Open
2002-0063PROTOCOL FOR A RESEARCH DATABASE FOR HEMATOPOIETIC STEM CELL TRANSPLANTATION AND MARROW TOXIC INJURIESOpen
NMDP2011-0624A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indicationsOpen